Changes in the prevalence of metabolic syndrome and smoking habits during a 10-year period and relation between these risk factors and ischemic heart disease among men aged 45-64 years;45-64 metu vyru metabolinio sindromo ir rukymo ipročiu paplitimo pokyčiai per 10 metu bei šiu rizikos veiksniu ryšys su išemine širdies liga

Medicina

Volumn 44, Issue 5, 2008, Pages 400-406

  Lukšiene, Dalia Ieva ^a   Černiauskiene, Liucija Rita ^a   Margevičiene, Lilija ^a   Tamošiunas, Abdonas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Ischemic heart disease; Metabolic syndrome; Smoking

Indexed keywords

ADULT; AGE; ANGINA PECTORIS; ARTICLE; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EVALUATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AGE FACTORS; ANGINA PECTORIS; ELECTROCARDIOGRAPHY; HUMANS; MALE; METABOLIC SYNDROME X; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 45749122005     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44050052     Document Type: Article

References (28)

1. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prevent Rehabil 2003; 10(Suppl 1):S1-78.
2. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3167-213.
3. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:307-12.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52(5):1210-4.
5. Baltali M, Gokcel A, Kiziltan HT, Korkmaz ME, Topcu S, Yalcin F, et al. Association between the metabolic syndrome and newly diagnosed coronary artery disease. Diabetes Nutr Metab 2003;16(3):169-75.
6. Lin RT, Lee WJ, Jeng CY, Sheu WH, Chen YT. Metabolic syndrome and its contribution to coronary artery disease in non-diabetic subjects. J Formos Med Assoc 2004;103(4):317-20.
7. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110(10):1245-50.
8. Černiauskiene LR, Domarkiene S, Lukšiene DI, Margevičiene L, Reklaitiene R, Tamošiunas A, et al. Metabolic syndrome and mortality from coronary heart disease in middle-aged men and women. Baltic Endocrinology 2005;1(1):5-10.
9. Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care 2006;29(3):625-30.
10. Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC. The metabolic syndrome and its components and the longterm risk of death in patients with coronary heart disease. Am Heart J 2006;151(2):514-21.
11. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, et al. Metabolic syndrome: Risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 2006;29(1):123-30.
12. Černiauskiene LR, Reklaitiene R, Lukšiene DI, Domarkiene S, Tamošiunas A, Margevičiene L. Association of metabolic syndrome with ischemic heart disease among middle-aged Kaunas population. Medicina (Kaunas) 2005;41(5):435-41.
13. Buivydaite K, Domarkiene S, Reklaitiene R, Tamošiunas A. The prevalence and trends of the smoking habits among middle-aged Kaunas population during 20 years and their relation with sociodemographic status. Medicina (Kaunas) 2003;39:999-1006.
14. Van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: A review. Thorax 2004;59:713-21.
15. Burke A, Fitzgerald GA. Oxidative stress and smoking-during induced vascular injury. Prog Cardiovasc Dis 2003;46:79-90.
16. Orosz Z, Csiszar A, Labinskyy N, Smith K, Kaminski PM, Ferdinandy P, et al. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: Role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 2007;292(1):H130-9.
17. Lykkesfeldt J, Viscovich M, Poulsen HE. Plasma malondialdehyde is induced by smoking: A study with balanced antioxidant profiles. Br J Nutr 2004;92:203-6.
18. World Health Organization MONICA Project. MONICA Manual: Monitoring of Trends and Determinants in Cardiovascular Disease. Geneva (Switzerland): Cardiovascular Disease Unit, WHO; 1990.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. London: John Wright; 1982.
20. Stein EA, Myers GL. National Cholesterol Education Program. Recommendations for triglycerides measurement: Executive summary. Clin Chem 1995;4:1421-6.
21. Warnick GR, Albers JJ. HDL cholesterol quantitation: Comparison of six precipitation methods and ultracentrifugation. In: Lippel K, editors. Report of the High Density Lipoprotein Methodology Workshop. NIH publication no. 79-1661. San Francisco, California: US Department of Health, Education, and Welfare; 1979. p. 53-69.
22. Lukšiene DI, Černiauskiene LR. Metabolinis sindromas bei širdies ir kraujagysliu ligu rizika. (The metabolic syndrome and risks of cardiovascular disease.) Medicinos teorija ir praktika 2006;12(2):114-20.
23. Bojarskiene F, Černiauskiene LR, Paunksnis A, Lukšiene DI. Metabolinio sindromo ir jo komponentu ryšys su katarakta. (Association of metabolic syndrome components with cataract.) Medicina (Kaunas) 2006;42(2):115-22.
24. Butnoriene J, Norkus A, Bunevičius R, Lašas L. Metabolinio sindromo diagnostikos kriteriju ivertinimas nustatant atsparuma insulinui. (Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance.) Medicina (Kaunas) 2006;42(6):455-63.
25. Tonstad S, Svendsen M. Premature coronary heart disease, cigarette smoking, and the metabolic syndrome. Am J Cardiol 2005;96(12):1681-5.
26. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B; D.E.S.I.R. Study Group. The metabolic syndrome in smokers. The D.E.S.I.R Study. Diabetes Metab 2003;29: 226-34.
27. Tytmonas G. Padidėjusio kūno masės indekso ir pilvinio nutukimo itaka metaboliniam sindromui išsivystyti. (The influence of increased body mass index and abdominal obesity on the development of metabolic syndrome.) Medicina (Kaunas) 2006;42(2):123-9.
28. Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med 2006; 45(18):1039-43.